adenosine monophosphate has been researched along with Angina at Rest in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moliterno, DJ | 1 |
Cattaneo, M | 1 |
Rich, JD; Wiviott, SD | 1 |
Fuchs-Kalinowska, J; Klem, J; Kopff, M; Puczkowski, S; Strzelczyk, M; Zakrzewska, I | 1 |
Oldroyd, KG; Storey, RF; Wilcox, RG | 1 |
Kirichuk, VF; Pozin, PIa; Rebrov, AP; Voskoboĭ, IV | 1 |
Ellborg, M; Jacobsson, F; Swahn, E; Wallentin, L | 1 |
3 review(s) available for adenosine monophosphate and Angina at Rest
Article | Year |
---|---|
Advances in antiplatelet therapy for ACS and PCI.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angina, Unstable; Aspirin; Blood Platelets; Cardiac Catheterization; Fibrinolytic Agents; Humans; Lactones; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyridines; Treatment Outcome | 2008 |
Platelet P2 receptors: old and new targets for antithrombotic drugs.
Topics: Adenosine; Adenosine Monophosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Interactions; Fibrinolytic Agents; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Syndrome; Thiophenes; Ticagrelor; Ticlopidine | 2007 |
New antiplatelet therapies for acute coronary syndromes.
Topics: Adenosine; Adenosine Monophosphate; Angina, Unstable; Blood Platelets; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Thiophenes; Ticagrelor; Treatment Outcome | 2007 |
3 trial(s) available for adenosine monophosphate and Angina at Rest
Article | Year |
---|---|
Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes.
Topics: Acute Disease; Adenosine Monophosphate; Adult; Aged; Angina, Unstable; Aspirin; Blood Coagulation Tests; Consumer Product Safety; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12 | 2001 |
[Lectin-induced platelet aggregation inpatients with unstable angina pectoris treated with anti-aggregation agents].
Topics: Adenosine Monophosphate; Angina, Unstable; Blood Platelets; Female; Humans; Lectins; Male; Middle Aged; Phytohemagglutinins; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 2001 |
Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction.
Topics: Adenosine Monophosphate; Aged; Angina, Unstable; Double-Blind Method; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Myocardial Infarction; Platelet Aggregation | 2002 |
1 other study(ies) available for adenosine monophosphate and Angina at Rest
Article | Year |
---|---|
5'-nucleotidase and adenosine deaminase activities in blood of patients with unstable angina pectoris.
Topics: 5'-Nucleotidase; Adenosine Deaminase; Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Angina, Unstable; Enzyme Activation; Female; Humans; Male; Middle Aged; Phosphorylation | 1997 |